Fiduciary Trust Co. decreased its position in Colgate-Palmolive (NYSE:CL) by 3.9% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 164,095 shares of the company’s stock after selling 6,723 shares during the quarter. Fiduciary Trust Co.’s holdings in Colgate-Palmolive were worth $11,955,000 at the end of the most recent quarter.
A number of other large investors have also recently modified their holdings of CL. Jacobi Capital Management LLC raised its holdings in Colgate-Palmolive by 125.5% during the third quarter. Jacobi Capital Management LLC now owns 1,443 shares of the company’s stock worth $104,000 after purchasing an additional 803 shares in the last quarter. Krilogy Financial LLC raised its holdings in Colgate-Palmolive by 23.0% during the second quarter. Krilogy Financial LLC now owns 1,547 shares of the company’s stock worth $115,000 after purchasing an additional 289 shares in the last quarter. Hanson & Doremus Investment Management raised its holdings in Colgate-Palmolive by 4.5% during the second quarter. Hanson & Doremus Investment Management now owns 1,630 shares of the company’s stock worth $121,000 after purchasing an additional 70 shares in the last quarter. Captrust Financial Advisors acquired a new stake in Colgate-Palmolive during the second quarter worth approximately $122,000. Finally, Harbour Capital Advisors LLC acquired a new stake in Colgate-Palmolive during the first quarter worth approximately $121,000. 72.83% of the stock is currently owned by hedge funds and other institutional investors.
In related news, insider Victoria L. Dolan sold 9,000 shares of Colgate-Palmolive stock in a transaction on Tuesday, November 14th. The shares were sold at an average price of $73.41, for a total value of $660,690.00. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, insider Victoria L. Dolan sold 10,000 shares of Colgate-Palmolive stock in a transaction on Thursday, November 9th. The shares were sold at an average price of $73.07, for a total transaction of $730,700.00. Following the completion of the transaction, the insider now owns 60,528 shares in the company, valued at $4,422,780.96. The disclosure for this sale can be found here. Over the last quarter, insiders sold 181,048 shares of company stock worth $13,168,995. 1.02% of the stock is currently owned by insiders.
Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, October 27th. The company reported $0.73 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.73. Colgate-Palmolive had a net margin of 15.10% and a return on equity of 2,782.56%. The firm had revenue of $3.97 billion for the quarter, compared to analyst estimates of $3.94 billion. During the same period last year, the firm posted $0.73 EPS. Colgate-Palmolive’s quarterly revenue was up 2.8% on a year-over-year basis. analysts predict that Colgate-Palmolive will post 2.88 earnings per share for the current fiscal year.
A number of analysts have weighed in on CL shares. Macquarie started coverage on shares of Colgate-Palmolive in a report on Thursday, September 14th. They set a “neutral” rating and a $76.00 price objective on the stock. Zacks Investment Research cut shares of Colgate-Palmolive from a “hold” rating to a “sell” rating in a report on Wednesday, September 20th. Morgan Stanley raised shares of Colgate-Palmolive from an “equal weight” rating to an “overweight” rating and lifted their target price for the company from $75.00 to $84.00 in a report on Monday, September 25th. Jefferies Group reaffirmed a “hold” rating and issued a $79.00 target price on shares of Colgate-Palmolive in a report on Thursday, September 28th. Finally, Royal Bank of Canada reaffirmed a “hold” rating and issued a $74.00 target price on shares of Colgate-Palmolive in a report on Sunday, October 8th. Three analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and five have assigned a buy rating to the company. The stock has an average rating of “Hold” and an average price target of $76.33.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
What are top analysts saying about Colgate-Palmolive? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Colgate-Palmolive and related companies.